RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.

ResMed’s recurring revenue model leverages device sales, consumables, and SaaS, with growth driven by rising diagnosis and ...

ResMed is one of the largest companies in the business of respiratory care devices. More specifically, it makes equipment ...

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre ...

Sydney: Sleep-breathing device maker ResMed plans to take global a doctor ‍education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, ⁠calling ...

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...

ResMed’s 2030 strategy focuses on empowering 500 million lives by the end of the decade through its digital health products and cloud-based software solutions. The company reported that it has already ...

The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...

In fact he sees the opposite. “It’s not actually a headwind, it’s a tailwind,” the Resmed chief executive officer told The Australian ahead of being honoured by The American Australian Association at ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...